Endogenous opioid peptides suppress cytokine-mediated upregulation of HIV- 1 expression in the chronically infected promonocyte clone U1

C. C. Chao, G. Gekker, W. S. Sheng, S. Hu, P. S. Portoghese, P. K. Peterson

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Opioid peptides appear to have an immunomodulatory activity. Using the chronically HIV-1-infected promonocyte clone U1, we investigated the effect of endogenous and synthetic opioid agonists on cytokine-induced HIV-1 expression. None of the endogenous or synthetic opioid agonists had an effect on constitutive HIV-1 expression. Opioid agonists such as methionine- enkephalin, dynorphin, and the κ receptor agonist, U50,488, dose-dependently suppressed (>40%) interleukin (IL)-6-induced upregulation of HIV-1 expression. Interestingly, opioid receptor antagonists (μ, δ, and κ types) also inhibited (>60%) IL-6-induced upregulation of HIV-1 expression. All opioid agonists and antagonists tested only modestly suppressed (<20%) tumor necrosis factor-α-induced upregulation of HIV-1 expression in U1 cell cultures. These data suggest that certain opioid peptides alter an IL-6- induced signal transduction pathway which triggers HIV-1 expression in the chronically infected promonocyte U1.

Original languageEnglish (US)
Pages (from-to)65-72
Number of pages8
JournalAdvances in experimental medicine and biology
Volume373
DOIs
StatePublished - 1995

Fingerprint

Dive into the research topics of 'Endogenous opioid peptides suppress cytokine-mediated upregulation of HIV- 1 expression in the chronically infected promonocyte clone U1'. Together they form a unique fingerprint.

Cite this